Company news
Turn Therapeutics Inc. news in 2025
Turn Therapeutics Inc.'s news releases, calls and decks from 2025, newest first.
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 13, 2025
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.
November 11, 2025
Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
November 11, 2025
Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications
November 4, 2025
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
October 30, 2025
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
October 22, 2025
Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025
October 20, 2025
Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors
October 15, 2025
Turn Therapeutics Appoints Arthur Golden to Board of Directors
October 14, 2025
Turn Therapeutics to Commence Trading Today on Nasdaq
October 8, 2025
Decks in 2025
- Investor Presentation (September 2025)
Investor deck · 24 slides · September 2025